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A B S T R A C T
In total, 309 blood culture supernatants were
tested for the presence of Burkholderia pseudomallei
antigen using an in-house coagglutination test
prepared by sensitising Cowan I staphylococcal
cells with B. pseudomallei polyclonal antiserum.
The coagglutination test gave a sensitivity, spe-
cificity, positive predictive value and negative
predictive value of 100% in comparison with
blood culture. A subset of 102 supernatants was
also tested for B. pseudomallei antigen using a
monoclonal antibody-based latex agglutination
test. The sensitivity, specificity, positive predic-
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tive value and negative predictive values of this
test were 100%, 90%, 75% and 100%, respect-
ively.
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Burkholderia pseudomallei, the causative agent of
melioidosis, is an emerging pathogen in India
[1–3]. Clinical manifestations are protean and this
has led to the infection being termed a ‘great
mimicker’. In a series of melioidosis cases, the
most frequent clinical presentation was septicae-
mia, sometimes associated with bacterial dissem-
ination to various organs, such as liver and
spleen, with the formation of abscesses [3]. It is
known that c. 50% of patients with acute septic-
aemic melioidosis die within 48 h of admission
[4]. To reduce mortality, it is essential to diagnose
early and treat appropriately [5]. Culture of
B. pseudomallei (the current standard diagnostic
method) is relatively time-consuming (96 h for
confirmation), and nucleic acid detection proto-
cols for use directly with blood or blood culture
supernatants have not been satisfactory in the
clinical setting [5,6]. A variety of immunological
tests have also been developed, but these have not
been used extensively in clinical laboratories.
The coagglutination test is used widely for the
detection of various aetiological agents causing
infectious diseases, and can be performed with
faeces [7,8], urine [9], sera [10,11] and blood
culture supernatants [12]. The present study
describes a coagglutination test to detect B.
pseudomallei in the blood culture supernatants of
patients with pyrexial illness. In addition, a
monoclonal antibody-based latex agglutination
(LA) test was evaluated using blood culture
supernatants [13,14].
The coagglutination test was evaluated with a
coded panel of 309 samples, comprising 255
clinical blood cultures positive for bacterial
growth, 53 blood cultures spiked with B. pseudo-
mallei, and one blood culture spiked with arabi-
nose-positive Burkholderia thailandensis (ATCC
700388). Of the 255 clinical blood cultures, eight
were from patients whose blood grew B. pseudo-
mallei, while the remaining 247 grew bacteria
other than B. pseudomallei (see below). Isolates
of B. pseudomallei, collected over a period of
9 years, were used for the spiking of broths; three
drops of B. pseudomallei culture broth, adjusted to
a 0.5· McFarland standard, and 4 mL of blood
from healthy individuals was inoculated into each
blood culture bottle. All blood cultures were
placed in an automated blood culture system
(MiniVITAL or Bact ⁄Alert; bioMe´rieux, Marcy-
l’Etoile, France). The blood cultures positive for
other bacteria contained Escherichia coli (n = 46),
Klebsiella spp. (n = 12), Enterobacter spp. (n = 9),
Citrobacter spp. (n = 3), Proteus spp. (n = 1),
Serratia spp. (n = 1), Salmonella enterica serotype
Typhi (n = 30), S. enterica serotype Paratyphi
(n = 8), S. enterica serotype Typhimurium
(n = 2), other Salmonella spp. (n = 4), Aeromonas
spp. (n = 2), non-01 non-0139 Vibrio spp. (n = 1),
Haemophilus influenzae (n = 1), non-fermenting
Gram-negative bacteria (n = 42), Pseudomonas
aeruginosa (n = 20), Staphylococcus aureus (n = 20),
methicillin-resistant Staphylococcus aureus (n = 4),
Streptococcus pneumoniae (n = 10), group B and G
streptococci (n = 2 each), haemolytic streptococci
(n = 9) and Enterococcus spp. (n = 18). These
samples were obtained from patients with pyrex-
ial illness who were admitted to the hospital of
the Christian Medical College (Vellore, India)
between February and April 2003. A subset of 102
blood culture broths were further subjected to a
monoclonal antibody-based LA test [13,14].
One-mL of formalin (10% v ⁄ v)-stabilised Co-
wan I staphylococcal cells (Cowan, NCTC no.
8530, WHO Prague centre no. 55 ⁄ 64) were treated
with 0.1 mL of methylene blue 1% w ⁄ v and
0.1 mL of Gram’s iodine 1% w ⁄ v. Rabbits were
immunised intravenously with whole-cell antigen
[15] at weekly intervals for 4 weeks. B. pseudomallei
polyvalent antiserum (0.2 mL) raised in rabbits [1]
was added to the stabilised staphylococcal cells,
which were then left at room temperature for
30 min with intermittent mixing. After sensitisa-
tion, the suspensions were centrifuged and the
pellets resuspended in 0.03 M phosphate-buffered
saline (0.15 M; pH 7.3) to a final cell concentration
of 2% v ⁄ v. This was used as detecting reagent
(Co A-BP). A control (Co A-NRS) was prepared
similarly using pooled normal rabbit serum in
order to detect non-specific reactions. The Co A
test was performed by mixing 40 lL of culture
supernatant (heated at 100C for 2 min and
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centrifuged) with 40 lL of Co A-BP and 40 lL of
Co A-NRS separately. The results were examined
visually after gentle rotation for 3 min; develop-
ment of clumps and clearing with Co A-BP, and
no reaction with Co A-NRS, was interpreted as a
positive result.
The LA reagent consisted of latex particles
sensitised with three different monoclonal anti-
bodies (5F8-IgM; 4B11-IgG3; 6G9-IgG2a) that
recognise epitopes on a 200-kDa surface antigen
present only in arabinose-negative B. pseudomal-
lei (kindly provided by S. Sirisinha, Mahidol
University, Bangkok, Thailand). The LA test was
performed by mixing equal amounts (35 lL) of
blood culture supernatants (heated at 100C for
2 min and centrifuged) with LA test and control
(latex sensitised with unrelated monoclonal
antibody and bovine serum albumin) reagents
on a glass slide. Clumps were observed visually
after rotation for 2 min [13,14]; development of
clumps and clearing with LA test reagent, and
no reaction with the control, was interpreted as
a positive result.
Of the 309 samples tested, the 53 spiked
samples and the eight samples positive for
B. pseudomallei by culture were detected cor-
rectly by the coagglutination test. The remaining
247 samples were negative by coagglutination.
The coagglutination reagent did not react with
the sample spiked with B. thailandensis. Com-
pared with culture, the coagglutination test had
a sensitivity, specificity, positive predictive
value and negative predictive value of 100%.
Of the subset of 102 samples tested by LA, 24
blood cultures containing B. pseudomallei were
detected correctly. However, there were also
eight false-positive results associated with
Gram-positive cocci (haemolytic streptococci,
Streptococcus pneumoniae, Enterococcus spp.) and
Salmonella spp. Thus, the LA test had sensitivity,
specificity, positive predictive value and negat-
ive predictive values of 100%, 90%, 75% and
100%, respectively. Smith et al. [16] showed
previously that latex particles coated with poly-
clonal antibodies detected B. pseudomallei anti-
gens from unconcentrated and concentrated
urine specimens [17] with a sensitivity of 18%
and 47%, respectively. Samosornsuk et al. [13]
and Anuntagool et al. [14], using the same LA
kit as that used in the present study, found no
false-positive results among the blood culture
supernatant samples tested. The reason for the
false-positive reactions (n = 8) in the present
study is unclear, but is probably related to
antigenic cross-reactions. Other groups have
evaluated LA tests for different targets, inclu-
ding a 30-kDa protein antigen [18], lipopolysac-
charide-specific antigens [19] and
exopolysaccharide-specific antigen [20], for the
rapid identification of B. pseudomallei in blood
culture supernatants. These tests had a sensitiv-
ity and specificity of ‡ 95% (Table 1).
Although the overall performance of all these
LA tests was satisfactory, none are commercially
available at present. The coagglutination reagent
described here is easy to prepare in-house, and
can be used in diagnostic laboratories with min-
imal equipment and technical expertise. In addi-
tion, the method is inexpensive, simple
and reproducible, with a high sensitivity and
specificity for the diagnosis of septicaemic
melioidosis.
Table 1. Comparison of results
obtained in studies detecting B. pseu-
domallei antigens in clinical materials
Year Test Antibody used Sensitivity % Specificity % Reference
1993 LA on culture
isolates
Polyclonal antibody 100 100 [16]
1995 LA on
concentrated
urine
Polyclonal antibody 47 100 [17]
1999 LA on blood
culture broth
Monoclonal antibody to
30-kDa antigen
94.1 98.3 [18]
1999 LA on blood
culture broth
Lipopolysaccharide-specific
monoclonal antibody
100 100 [19]
1999 LA on culture
isolates
Exopolysaccharide-specific
monoclonal antibody
100 100 [20]
1999 LA on blood
culture broth
Monoclonal antibody 100 100 [13]
2000 LA on blood
culture broth
Monoclonal antibody 95.1 99.7 [14]
2004 Coagglutination on
blood culture broth
Polyclonal antibody 100 100 This study
LA, latex agglutination.
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This prospective study compared the clinical and
socio-economic impact of laboratory-confirmed
influenza and respiratory syncytial virus (RSV)
infection on healthy children and their families.
Among 1520 otherwise healthy children aged
< 15 years attending the Emergency Department
for acute conditions other than trauma, influenza
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